ASPARAGINASE ERWINIA CHRYSANTHEMI
ASPARAGINASE ERWINIA CHRYSANTHEMI is listed in the FDA National Drug Code directory with 1 NDC code. Available dosage form: solution.
Drug Details
- Generic Name
- ASPARAGINASE ERWINIA CHRYSANTHEMI
- Brand Names
- N/A
- Application Number
- Sponsor
- AGC Biologics A/S
- NDC Codes
- 1
- Dosage Forms
- SOLUTION
- Routes
- N/A
- Active Ingredients
- ASPARAGINASE ERWINIA CHRYSANTHEMI
Indications and Usage
1 INDICATIONS AND USAGE RYLAZE is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) in adult and pediatric patients 1 month or older who have developed hypersensitivity to E. coli -derived asparaginase. RYLAZE is an asparagine specific enzyme indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) in adult and pediatric patients 1 month or older who have developed hypersensitivity to E. coli -derived asparaginase. ( 1 )